Gavreto

(pralsetinib)
pralsetinib 100 MG Oral Capsule [Gavreto]
NO BLACK BOX WARNING

Dosage & administration

Select patients for treatment with GAVRETO based on the presence of a RET gene fusion or gene mutation.

The recommended dosage in adults and pediatric patients 12 years and older is 400 mg orally once daily on an empty stomach (no food intake for at least 2 hours before and at least 1 hour after taking GAVRETO).

drug label

Gavreto prescribing information

Have more Gavreto questions?

Submit MSL Request
Learn More

Need to report a Gavreto issue?

ONLINE FORM
Report adverse event
Learn More

prior authorization

Gavreto Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Coverage Authorization Request
Coverage Authorization Appeals
Learn More

Benefits investigation

Prescriber Service Form - Online Portal
Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRAND
Reimbursement help (FRM) resources
Learn More

financial assistance

Gavreto Financial assistance options

Co-pay savings program

commercial only
Prescriber Service Form - Online Portal
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only
Prescriber Service Form - Online Portal
Gavreto Sure Start Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Prescriber Service Form - Online Portal
Genentech Patient Foundation Application Form - Prescriber Form
Learn More

patient education

Gavreto Patient education

Getting started on Gavreto

NOT PROVIDED BY BRAND
Instructions For Use: Metastatic Non-Small Cell Lung Cancer

NOT PROVIDED BY BRAND
Instructions For Use: Thyroid Cancer

Patient toolkit

About Gavreto: Metastatic Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Gavreto: Metastatic Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Metastatic Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Biomarker Testing Fact Sheet: Metastatic Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
RET+ Metastatic Non-Small Cell Lung Cancer Fact Sheet
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Doctor Discussion Guide: Metastatic Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Metastatic Non-Small Cell Lung Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Gavreto: Thyroid Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Gavreto: Thyroid Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Thyroid Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Biomarker Testing Fact Sheet - Thyroid Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
RET+ Advanced Thyroid Cancer Fact Sheet
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Doctor Discussion Guide - Thyroid Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Thyroid Cancer
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Updates about Gavreto - Sign Up
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Gavreto Fact Sheet
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.